187 related articles for article (PubMed ID: 3177373)
1. Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis--a prospective, randomized comparison of intermittent v continuous therapy.
Boyce NW; Wood C; Thomson NM; Kerr P; Atkins RC
Am J Kidney Dis; 1988 Oct; 12(4):304-6. PubMed ID: 3177373
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
[TBL] [Abstract][Full Text] [Related]
3. A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.
Cheng IK; Fang GX; Chau PY; Chan TM; Tong KL; Wong AK; Li CS; Lo WK; Cheung KO; Kumana CR
Perit Dial Int; 1998; 18(4):371-5. PubMed ID: 10505557
[TBL] [Abstract][Full Text] [Related]
4. Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?
Bailie GR; Morton R; Ganguli L; Keaney M; Waldek S
Nephron; 1987; 46(3):316-8. PubMed ID: 3627326
[TBL] [Abstract][Full Text] [Related]
5. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.
Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB
Nephron; 1987; 45(4):283-5. PubMed ID: 3587467
[TBL] [Abstract][Full Text] [Related]
6. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
7. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.
Wong KM; Chan YH; Cheung CY; Chak WL; Choi KS; Leung SH; Leung J; Chau KF; Tsang DN; Li CS
Am J Kidney Dis; 2001 Jul; 38(1):127-31. PubMed ID: 11431192
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
9. A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD).
Friedland JS; Iveson TJ; Fraise AP; Winearls CG; Selkon JB; Oliver DO
J Antimicrob Chemother; 1990 Dec; 26 Suppl F():77-81. PubMed ID: 2292548
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.
Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H
Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Beaman M; Solaro L; McGonigle RJ; Michael J; Adu D
Nephron; 1989; 51(1):51-5. PubMed ID: 2644565
[TBL] [Abstract][Full Text] [Related]
12. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).
Schaefer F; Klaus G; Müller-Wiefel DE; Mehls O
J Am Soc Nephrol; 1999 Jan; 10(1):136-45. PubMed ID: 9890319
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin kinetics during continuous ambulatory peritoneal dialysis.
Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
Clin Pharmacol Ther; 1983 Nov; 34(5):631-7. PubMed ID: 6627823
[TBL] [Abstract][Full Text] [Related]
14. Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis.
Lye WC; van der Straaten JC; Leong SO; Sivaraman P; Tan SH; Tan CC; Lee EJ
Perit Dial Int; 1999; 19(4):357-60. PubMed ID: 10507817
[TBL] [Abstract][Full Text] [Related]
15. Once weekly intraperitoneal therapy for gram-positive peritonitis.
Morse GD; Nairn DK; Walshe JJ
Am J Kidney Dis; 1987 Oct; 10(4):300-5. PubMed ID: 3661551
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gray HH; Goulding S; Eykyn SJ
Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
[TBL] [Abstract][Full Text] [Related]
18. A comparison between oral ciprofloxacin and intra-peritoneal vancomycin and gentamicin in the treatment of CAPD peritonitis.
Bennett-Jones DN; Russell GI; Barrett A
J Antimicrob Chemother; 1990 Dec; 26 Suppl F():73-6. PubMed ID: 2292547
[TBL] [Abstract][Full Text] [Related]
19. Treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
Horton MW; Deeter RG; Sherman RA
Clin Pharm; 1990 Feb; 9(2):102-18. PubMed ID: 2407420
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.
Lye WC; Lee EJ; van der Straaten J
Perit Dial Int; 1993; 13 Suppl 2():S348-50. PubMed ID: 8399607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
